Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Long-Term Investments 2010-2024 | MKKGY

Merck long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Merck long-term investments for the quarter ending September 30, 2024 were $1.202B, a 11.2% increase year-over-year.
  • Merck long-term investments for 2023 were $1.065B, a 5.29% increase from 2022.
  • Merck long-term investments for 2022 were $1.011B, a 6.46% decline from 2021.
  • Merck long-term investments for 2021 were $1.081B, a 917.9% increase from 2020.
  
Merck Annual Long-Term Investments
(Millions of US $)
2023 $1,065
2022 $1,011
2021 $1,081
2020 $106
2019 $827
2018 $720
2017 $502
2016 $241
2015 $146
2014 $125
2013 $103
2012 $125
2011 $
2010 $
2009 $
Merck Quarterly Long-Term Investments
(Millions of US $)
2024-09-30 $1,202
2024-06-30 $1,147
2024-03-31 $1,163
2023-12-31 $1,065
2023-09-30 $1,081
2023-06-30 $1,138
2023-03-31 $1,033
2022-12-31 $1,011
2022-09-30 $972
2022-06-30 $963
2022-03-31 $1,016
2021-12-31 $1,081
2021-09-30 $936
2021-06-30 $896
2021-03-31 $928
2020-12-31 $106
2020-09-30 $106
2020-06-30 $741
2020-03-31 $763
2019-12-31 $827
2019-09-30 $713
2019-06-30 $738
2019-03-31 $676
2018-12-31 $720
2018-09-30 $544
2018-06-30 $526
2018-03-31 $562
2017-12-31 $502
2017-09-30 $584
2017-06-30 $309
2017-03-31 $236
2016-12-31 $241
2016-09-30 $211
2016-06-30 $208
2016-03-31 $183
2015-12-31 $146
2015-09-30 $113
2015-06-30 $126
2015-03-31 $124
2014-12-31 $125
2014-09-30 $119
2014-06-30 $124
2014-03-31 $109
2013-12-31 $103
2013-09-30 $100
2013-06-30 $92
2013-03-31 $89
2012-12-31 $125
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30 $5
2011-03-31
2010-12-31
2010-09-30 $6
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.527B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.364B 28.23
Chugai Pharmaceutical (CHGCY) Japan $72.468B 28.23
Takeda Pharmaceutical (TAK) Japan $42.160B 8.77
Sandoz Group AG (SDZNY) Switzerland $17.930B 0.00
Astellas Pharma (ALPMY) Japan $17.409B 16.03
United Therapeutics (UTHR) United States $16.082B 15.82
Neurocrine Biosciences (NBIX) United States $13.958B 36.96
Summit Therapeutics (SMMT) United States $13.532B 0.00
Shionogi (SGIOY) Japan $11.859B 11.88
Madrigal Pharmaceuticals (MDGL) United States $6.844B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.477B 0.00
Corcept Therapeutics (CORT) United States $5.236B 39.66
Crinetics Pharmaceuticals (CRNX) United States $4.781B 0.00
PTC Therapeutics (PTCT) United States $3.539B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.817B 0.00
Dyne Therapeutics (DYN) United States $2.591B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.567B 11.63
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.404B 14.37
NewAmsterdam Pharma (NAMS) Netherlands $2.398B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.307B 0.00
Soleno Therapeutics (SLNO) United States $1.971B 0.00
Indivior (INDV) United States $1.723B 7.02
Xencor (XNCR) United States $1.665B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Ocular Therapeutix (OCUL) United States $1.374B 0.00
Harrow (HROW) United States $1.302B 0.00
Guardian Pharmacy Services (GRDN) United States $1.259B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.256B 0.00
Ardelyx (ARDX) United States $1.213B 0.00
Enliven Therapeutics (ELVN) United States $1.168B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.060B 0.00
ARS Pharmaceuticals (SPRY) United States $1.041B 0.00
Collegium Pharmaceutical (COLL) United States $0.923B 5.04
Bioventus (BVS) United States $0.863B 27.26
Cronos Group (CRON) Canada $0.788B 0.00
Relay Therapeutics (RLAY) United States $0.720B 0.00
Oruka Therapeutics (ORKA) United States $0.699B 0.00
USANA Health Sciences (USNA) United States $0.694B 12.86
Ironwood Pharmaceuticals (IRWD) United States $0.693B 0.00
Elite Pharmaceuticals (ELTP) United States $0.587B 0.00
Tourmaline Bio (TRML) United States $0.529B 0.00
Savara (SVRA) United States $0.527B 0.00
Xeris Biopharma Holdings (XERS) United States $0.516B 0.00
Verve Therapeutics (VERV) United States $0.509B 0.00
Altimmune (ALT) United States $0.506B 0.00
ProKidney (PROK) United States $0.505B 0.00
OmniAb (OABI) United States $0.494B 0.00
Zevra Therapeutics (ZVRA) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Siga Technologies (SIGA) United States $0.446B 5.20
KalVista Pharmaceuticals (KALV) United States $0.438B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
Akebia Therapeutics (AKBA) United States $0.415B 0.00
Korro Bio (KRRO) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.381B 0.00
Jupiter Neurosciences (JUNS) United States $0.347B 0.00
Avita Medical (RCEL) United States $0.335B 0.00
Aquestive Therapeutics (AQST) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.311B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.305B 123.71
4D Molecular Therapeutics (FDMT) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 16.00
Amylyx Pharmaceuticals (AMLX) United States $0.268B 0.00
Larimar Therapeutics (LRMR) United States $0.256B 0.00
Heron Therapeutics (HRTX) United States $0.243B 0.00
Profound Medical (PROF) Canada $0.237B 0.00
Inhibikase Therapeutics (IKT) United States $0.221B 0.00
Lexeo Therapeutics (LXEO) United States $0.221B 0.00
Silence Therapeutics (SLN) United Kingdom $0.215B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Lyell Immunopharma (LYEL) United States $0.188B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Acrivon Therapeutics (ACRV) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
VAXART, INC (VXRT) United States $0.163B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
Metagenomi (MGX) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.137B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Achieve Life Sciences (ACHV) Canada $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.121B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
ElectroCore (ECOR) United States $0.110B 0.00
Inotiv (NOTV) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Pyxis Oncology (PYXS) United States $0.101B 0.00
Context Therapeutics (CNTX) United States $0.089B 0.00
Century Therapeutics (IPSC) United States $0.088B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Journey Medical (DERM) United States $0.084B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.081B 21.25
PMV Pharmaceuticals (PMVP) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.069B 0.00
OptiNose (OPTN) United States $0.067B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.067B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
FibroGen (FGEN) United States $0.053B 0.00
Scienture Holdings (SCNX) United States $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
AleAnna (ANNA) United States $0.051B 0.00
Nutriband (NTRB) United States $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
VYNE Therapeutics (VYNE) United States $0.049B 0.00
Surrozen (SRZN) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.046B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
BioVie (BIVI) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Traws Pharma (TRAW) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.88